Subjective side effects of antipsychotics and medication adherence in people with schizophrenia

Journal of Advanced Nursing

Volumn 65, Issue 3, 2009, Pages 534-543

  McCann, Terence V ^a   Clark, Eileen ^b   Lu, Sai ^a  

^a VICTORIA UNIVERSITY   (Australia)

^b LA TROBE UNIVERSITY   (Australia)

Author keywords

Antipsychotics; Liverpool University Neuroleptic Side effect Rating Scale; Medication adherence; Schizophrenia; Side effects; Survey

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; AGED; ARTICLE; FEMALE; HUMAN; MALE; MIDDLE AGED; MOTIVATION; PATIENT COMPLIANCE; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RECURRENT DISEASE; RISK FACTOR; SCHIZOPHRENIA; STATISTICS;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MOTIVATION; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STATISTICS AS TOPIC; YOUNG ADULT;

EID: 59449097260     PISSN: 03092402     EISSN: 13652648     Source Type: Journal    
DOI: 10.1111/j.1365-2648.2008.04906.x     Document Type: Article

References (35)

1. Adams J. Scott J. (2000) Predicting medication adherence in severe mental disorders. Acta Psychiatrica Scandinavica 101 (2 119 124.
2. American Psychiatric Association (2000) Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. American Psychiatric Association, Washington, DC.
3. Anderson T.R., Goldberg J.F. Harrow M. (n.d A review of medication side effects and treatment adherence in bipolar disorder. Psychiatry Weekly. Retrieved from http://www.psychweekly.com/aspx/Article/articledetail.aspx? articleid=32 on 17 March 2008.
4. Bouman W.P. Pinner G. (2002) Use of atypical medication antipsychotic drugs in old age psychiatry. Advances in Psychiatric Treatment 8, 49 58.
5. Compton M.T., Rudisch B.E., Weiss P.S., West J.C. Kaslow N.J. (2005) Predictors of psychiatrist-reported treatment-compliance problems among patients in routine U.S. psychiatric care. Psychiatry Research 137 (1-2 29 36.
6. Cutler A.J. (2003) Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology 28, 69 82.
7. Day J.C., Wood G., Dewey M. Bentall R.P. (1995) A self-rating scale for measuring neuroleptic side effects validation in a group of schizophrenic patients. British Journal of Psychiatry 166, 650 653.
8. Haddad P.M. Sharma S.G. (2007) Adverse effects of atypical medication antipsychotics: differential risk and clinical implications. CNS Drugs 21 (11 911 936.
9. Knegtering H., van der Moolen A.E.G.M., Castelein S., Kluiter H. van den Bosch R.J. (2003) What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology 28, 109 123.
10. Lacro J.P., Dunn L.B., Dolder C.R., Leckband S.G. Jeste D.V. (2002) Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. Journal of Clinical Psychiatry 63 (10 892 909.
11. Lambert T.J.R., Cock N., Alcock S.J., Kelly D.L. Conley R.R. (2003) Measurement of antipsychotic-induced side effects: support for the validity of a self-report (LUNSERS) versus structured interview (UKU) approach to measurement. Human Psychopharmacology: Clinical and Experimental 18, 405 411.
12. Lambert M., Conus P., Eide P., Mass R., Karow A., Moritz S., Golks D. Naber D. (2004) Impact of present and past antipsychotic side effects on attitude toward typical antipsychotic treatment and adherence. European Psychiatry 19, 415 422.
13. Lieberman J.A., Stroup T.S., McEvoy J.P., Swartz M.S., Rosenheck R.A., Perkins D.O., Keefe R.S., Davis S.M., Davis C.E., Lebowitz B.D., Severe J. Hsiao J.K. (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 353 (12 1209 1223.
14. Liu-Seifert H., Adams D.H. Kinon B.J. (2005) Discontinuation of treatment of schizophrenic patients is driven by poor symptom response: a pooled post-hoc analysis of four atypical medication antipsychotic drugs. BMC Medicine 3, 21.
15. Loffler W., Kilian R., Toumi M. Angermeyer M.C. (2003) Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment. Pharmacopsychiatry 36 (3 105 112.
16. McEnany G.P. (2007) Psychopharmacologic strategies and associated challenges in the long-term treatment of schizophrenia. Journal of the American Psychiatric Nurses Association 13 (5 S6 S15.
17. Morrison P., Gaskill D., Meehan T., Lunney P., Lawrence G. Collings P. (2000) The use of the Liverpool University neuroleptic side-effect rating scale (LUNSERS) in clinical practice. Australian and New Zealand Journal of Mental Health Nursing 9, 166 176.
18. Mutsatsa S.H., Joyce E.M., Hutton S.B., Webb E., Gibbins H., Paul S. Barnes T.R. (2003) Clinical correlates of early medication adherence: West London first episode schizophrenia study. Acta Psychiatrica Scandinavica 108 (6 439 446.
19. Nunnally J.O. (1978) Psychometric Theory. McGraw-Hill, New York, NY.
20. Pallant J. (2005) SPSS Survival Manual: A Step by Step Guide to Data Analysis Using SPSS. Allen & Unwin, Sydney.
21. Perkins D.O. (2002) Predictors of noncompliance in patients with schizophrenia. Journal of Clinical Psychiatry 63 (12 1121 1128.
22. Perkins D.O., Johnson J.L., Hamer R.M., Zipursky R.B., Keefe R.S., Centorrhino F., Green A.I., Glick I.B., Kahn R.S., Sharma T., Tohen M., McEvoy J.P., Weiden P.J. Lieberman J.A. (2006) Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophrenia Research 83, 53 63.
23. Pinikahana J., Happell B., Taylor M. Keks N.A. (2002) Exploring the complexity of compliance in schizophrenia. Issues in Mental Health Nursing 23 (5 513 528.
24. Remington G., Kwon J., Collins A., Laporte D., Mann S. Christensen B. (2007) The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia. Schizophrenia Research 90, 229 237.
25. Rettenbacher M.A., Hofer A., Eder U., Hummer M., Kemmler G., Weiss E.M. Fleischhacker W.W. (2004) Compliance in schizophrenia: psychopathology, side effects, and patients' attitudes toward the illness and medication. Journal of Clinical Psychiatry 65 (9 1211 1218.
26. Robinson D., Woerner M.G., Alvir J.M., Bilder R., Goldman R., Geisler S., Koreen A., Sheitman B., Chakos M., Mayerhoff D. Lieberman J.A. (1999) Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry 56 (3 241 247.
27. Robinson D.G., Woerner M.G., Alvir J.M.J., Bilder R.M., Hinrichsen G.A. Lieberman J.A. (2002) Predictors of medication discontinuation by patients with first-episode schizophrenia and schizoaffective disorder. Schizophrenia Research 57, 202 219.
28. Rogers A., Day J.C., Williams B., Randall F., Wood P., Healy D. Bentall R.P. (1998) The meaning and management of neuroleptic medication: a study of patients with a diagnosis of schizophrenia. Social Science & Medicine 47 (9 1313 1323.
29. Scott J. Pope M. (2002) Nonadherence with mood stabilizers: prevalence and predictors. Journal of Clinical Psychiatry 63 (5 384 390.
30. Sieber J.E. (1992) Planning Ethically Responsible Research. Sage, Newbury Park, CA.
31. Sullivan G., Wells K.B. Leake B. (1992) Clinical factors associated with better quality of life in a seriously mentally ill population. Hospital and Community Psychiatry 43, 794 799.
32. Velligan D.I., Lam F., Ereshefsky L. Miller A.L. (2003) Psychopharmacology: perspectives on medication adherence and atypical medication antipsychotic medications. Psychiatric services 54 (5 665 667.
33. Weiden P.J., Mackell J.A. McDonnell D.D. (2004) Obesity as a risk factor for antipsychotic noncompliance. Schizophrenia Research 66 (1 51 57.
34. Weiss U., Marksteiner J., Kemmler G., Saria A. Aichhorn W. (2005) Effects of age and sex on olanzapine plasma concentrations. Journal of Clinical Psychopharmacology 25 (6 570 574.
35. Zygmunt A., Olfson M., Boyer C.A. Mechanic D. (2002) Interventions to improve medication adherence in schizophrenia. American Journal of Psychiatry 159 (10 1653 1664.